Spire Wealth Management’s CalciMedica CALC Stock Holding History

Spire Wealth Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-86	Closed	-$4K	–	2929
2021 Q3	$4K	Hold	86	–	–	﹤0.01%	2322
2021 Q2	$7K	Buy	+86	New	+$5.64K	﹤0.01%	2219

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Spire Wealth Management's CALC Position: Q4 2021 in Review

Spire Wealth Management sold out of CalciMedica (CALC) in Q4 2021, closing a stake of 86 shares — an estimated $4K sold.

Spire Wealth Management first reported a position in CALC in Q2 2021 and held it in 2 quarters. The position peaked at $7K in Q2 2021. 28 funds tracked by Wall St. Rank hold CALC as of Q4 2021.

Spire Wealth Management reported no remaining CalciMedica position as of Q4 2021 after selling out during the quarter.
Spire Wealth Management sold 86 CalciMedica shares in Q4 2021, an estimated $4K.
Spire Wealth Management first reported a position in CalciMedica in Q2 2021 and held it in 2 quarters.
Spire Wealth Management's CalciMedica position peaked at $7K in Q2 2021.
28 funds tracked by Wall St. Rank held CalciMedica as of Q4 2021.

Based on Spire Wealth Management's 13F filing for Q4 2021, filed 14 Jan 2022.